COPENHAGEN, Denmark, Feb. 10. 2012 (GLOBE NEWSWIRE) -- Genmab A/S (OMX:GEN) announced today it had reached the second pre-clinical milestone in the collaboration with H. Lundbeck A/S, triggering a €1 million payment.
COPENHAGEN, Denmark, Feb. 10. 2012 (GLOBE NEWSWIRE) -- Genmab A/S (OMX:GEN) announced today it had reached the second pre-clinical milestone in the collaboration with H. Lundbeck A/S, triggering a €1 million payment.
